655-P: Evaluation of Accuracy and Longevity of an Implantable CGM System through 365 Days

Background: The PROMISE Clinical Trial, conducted to assess safety and accuracy of a 180-day implantable CGM System, had 43 subjects implanted with a modified sensor containing sacrificial boronic acid (SBA) to reduce the degradation of the boronic acid glucose-binding moieties. In-home use to 365 d...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2022-06, Vol.71 (Supplement_1)
Hauptverfasser:	JACQUIN, ARNAUD E., AL-KHAWI, LUJAIN, SANCHEZ, PATRICIA, MOHANTY, SANAT, TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Clinical trials Diabetes Glucose Glucose monitoring Sensors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!